Carlos Alberto
Montilla Morales
Profesor Asociado CC. Salud
Hospital Universitario Central de Asturias
Oviedo, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario Central de Asturias (18)
2024
2021
-
Food groups associated with immune-mediated inflammatory diseases: a Mendelian randomization and disease severity study
European Journal of Clinical Nutrition, Vol. 75, Núm. 9, pp. 1368-1382
2019
-
Genetic variation at the glycosaminoglycan metabolism pathway contributes to the risk of psoriatic arthritis but not psoriasis
Annals of the Rheumatic Diseases, Vol. 78, Núm. 3, pp. 355-364
-
Spanish Registry of Recent-onset Psoriatic Arthritis (REAPSER study): Aims and methodology
Reumatologia Clinica, Vol. 15, Núm. 5, pp. 252-257
-
Very low disease activity, DAPSA remission, and impact of disease in a Spanish population with psoriatic arthritis
Journal of Rheumatology, Vol. 46, Núm. 7, pp. 710-715
2018
-
Recommendations for the use of methotrexate in psoriatic arthritis
Reumatologia Clinica, Vol. 14, Núm. 4, pp. 183-190
-
Recommendations of the Spanish Society of Rheumatology on treatment and use of systemic biological and non-biological therapies in psoriatic arthritis
Reumatologia Clinica, Vol. 14, Núm. 5, pp. 254-268
2016
-
Association of IL1Β (-511 A/C) and IL6 (-174 G > C) polymorphisms with higher disease activity and clinical pattern of psoriatic arthritis
Clinical Rheumatology, Vol. 35, Núm. 7, pp. 1789-1794
-
Etoricoxib in ankylosing spondylitis: Is there a role for active patients refractory to traditional NSAIDs?
Clinical and Experimental Rheumatology, Vol. 34, Núm. 1, pp. 94-99
-
Urine metabolome profiling of immune-mediated inflammatory diseases
BMC Medicine, Vol. 14, Núm. 1
2015
-
A deletion at adamts9-magi1 locus is associated with psoriatic arthritis risk
Annals of the Rheumatic Diseases, Vol. 74, Núm. 10, pp. 1875-1881
-
Variability in the prescription of non-biologic disease-modifying antirheumatic drugs for the treatment of spondyloarthritis in Spain
Seminars in Arthritis and Rheumatism, Vol. 44, Núm. 6, pp. 633-640
2014
-
Ankylosing spondylitis without axial progression: Analysis of associated factors
Journal of Rheumatology, Vol. 41, Núm. 12, pp. 2409-2412
-
PDE3A-SLCO1C1 locus is associated with response to anti-tumor necrosis factor therapy in psoriatic arthritis
Pharmacogenomics, Vol. 15, Núm. 14, pp. 1763-1769
-
Recommendations for the coordinated management of psoriatic arthritis by rheumatologists and dermatologists: A Delphi study
Actas Dermo-Sifiliograficas
-
Standards of care for patients with spondyloarthritis
Rheumatology International, Vol. 34, Núm. 2, pp. 165-170
2013
-
Diferente expresión clínica de los pacientes con espondilitis anquilosante según el sexo en función del tiempo de evolución. Datos de REGISPONSER
Reumatologia Clinica, Vol. 9, Núm. 4, pp. 221-225
2012
-
Risk variants for psoriasis vulgaris in a large case-control collection and association with clinical subphenotypes
Human Molecular Genetics, Vol. 21, Núm. 20, pp. 4549-4557